Anixa Biosciences (ANIX) Minority Interest (2018 - 2026)

Anixa Biosciences (ANIX) has reported Minority Interest for 9 consecutive years, with -$1.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Minority Interest fell 7.66% year-over-year to -$1.3 million; the trailing twelve-month figure through Apr 2026 stood at -$1.3 million (down 7.66% YoY), and the FY2025 full-year result was -$1.2 million, down 9.1% from the prior year.
• Minority Interest eased to -$1.3 million in Q2 2026 per ANIX's latest filing, from -$1.2 million in the prior quarter.
• Across five years, Minority Interest topped out at -$721000.0 in Q1 2022 and bottomed at -$1.3 million in Q2 2026.
• Historically, Minority Interest has averaged -$999117.6 across 5 years, with a median of -$1.0 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Minority Interest plunged 38.37% in 2022, then decreased 7.66% in 2026.
• Over 5 years, Minority Interest stood at -$847000.0 in 2022, then decreased by 14.05% to -$966000.0 in 2023, then fell by 14.91% to -$1.1 million in 2024, then dropped by 9.1% to -$1.2 million in 2025, then dropped by 3.3% to -$1.3 million in 2026.
• According to Business Quant data, Minority Interest over the past three periods registered -$1.3 million, -$1.2 million, and -$1.2 million for Q2 2026, Q4 2025, and Q3 2025 respectively.